We will present our antibody platform to develop a new generation of antibody-drug conjugates for cancer treatment of our pets. Thanks to this opportunity, we will pitch our SmarbAb solution to experts and investors aiming to catapult our start-up to deliver safer and more effective therapeutics for Animal Health. We look forward to meeting everyone next week in Boston.